Endpoints News 12. Dez. 2025 #SABCS25: Celcuity further details Phase 3 win; Relay’s PI3Kα inhibitor’s consistent performance; and more
Endpoints News 12. Dez. 2025 Innovent’s obesity drug data in adolescents; Everest gets rights to PCSK9 inhibitor
Endpoints News 12. Dez. 2025 FDA broadens label for Amgen's Uplizna as it enters rare disease competition
Endpoints News 11. Dez. 2025 Top Trump lawyer calls on SCOTUS to reverse 'skinny' generic drug label decision
Endpoints News 11. Dez. 2025 Rhythm reports Imcivree’s key weight loss data from Phase 2 Prader-Willi trial
Endpoints News 11. Dez. 2025 AC Immune says early biomarker data are promising in Parkinson's, but clinical benefit remains unclear
Endpoints News 11. Dez. 2025 Corbus’ obesity pill posts muted weight loss data; Disco adds another €16M in seed funding
Endpoints News 11. Dez. 2025 Zealand inks deal with OTR Therapeutics as it spells out broader metabolic disease ambitions